JUAN FRANCISCO
DELGADO JIMÉNEZ
Catedrático de universidad
Pablo
García Pavía
Pablo García Pavía-rekin lankidetzan egindako argitalpenak (10)
2024
-
N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study
European Journal of Heart Failure, Vol. 26, Núm. 4, pp. 776-784
2023
-
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial
European Journal of Heart Failure, Vol. 25, Núm. 3, pp. 373-385
2020
-
Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 561-568
-
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5
Heart Rhythm, Vol. 17, Núm. 6, pp. 945-954
-
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial
JACC: Basic to Translational Science, Vol. 5, Núm. 4, pp. 317-327
-
Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure
REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164
2019
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397
2018
-
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462
2016
-
Idiopathic Restrictive Cardiomyopathy Is Primarily a Genetic Disease
Journal of the American College of Cardiology
2013
-
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184